- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancer Cell International, 4.2004, (Suppl 1):S.1. - Association for Immunotherapy of Cancer: Cancer Immunotherapy – 2nd Annual Meeting Mainz, Germany. 6–7 May 2004
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2004
- Creator
- URN
-
urn:nbn:de:hebis:30-44495
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Weth, Robert
- Biburger, Markus
- Wels, Winfried S.
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2004
Other Objects (12)
Bispecific costimulatory molecules for activation of tumor-killing lymphocytes
Modulation of lytic molecules restrain serial killing in γδ T lymphocytes
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells
Improvement of pharmacokinetics of small recombinant bispecific antibody molecules
Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies
Mammalian display platform for the maturation of bispecific TCR-based molecules
Respirasome-mediated Activation of T-Lymphocytes
A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART®
Bispecific antibodies
Bispecific antibodies
MALT1 phosphorylation controls activation of T lymphocytes
Probing the killing potency of tumor-infiltrating lymphocytes on microarrayed colorectal cancer tumoroids
Bispecific costimulatory molecules for activation of tumor-killing lymphocytes
Modulation of lytic molecules restrain serial killing in γδ T lymphocytes
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells
Improvement of pharmacokinetics of small recombinant bispecific antibody molecules
Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies
Mammalian display platform for the maturation of bispecific TCR-based molecules
Respirasome-mediated Activation of T-Lymphocytes
A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART®
Bispecific antibodies
Bispecific antibodies
MALT1 phosphorylation controls activation of T lymphocytes
Probing the killing potency of tumor-infiltrating lymphocytes on microarrayed colorectal cancer tumoroids
Bispecific costimulatory molecules for activation of tumor-killing lymphocytes
Modulation of lytic molecules restrain serial killing in γδ T lymphocytes
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells
Improvement of pharmacokinetics of small recombinant bispecific antibody molecules
Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies
Mammalian display platform for the maturation of bispecific TCR-based molecules
Respirasome-mediated Activation of T-Lymphocytes
A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART®
Bispecific antibodies
Bispecific antibodies
MALT1 phosphorylation controls activation of T lymphocytes